Avidity Biosciences (RNA) Soars 11.3%: Is Further Upside Left in the Stock? [Yahoo! Finance]
Avidity Biosciences to Participate in Upcoming Investor Conference
Avidity Biosciences Completes Enrollment in Biomarker Cohort in Phase 1/2 FORTITUDE™ Trial for Delpacibart Braxlosiran (del-brax) in People Living with Facioscapulohumeral Muscular Dystrophy [Yahoo! Finance]
Avidity Biosciences Completes Enrollment in Biomarker Cohort in Phase 1/2 FORTITUDE™ Trial for Delpacibart Braxlosiran (del-brax) in People Living with Facioscapulohumeral Muscular Dystrophy
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)